NCT06078592View on ClinicalTrials.gov

Comparison of Efficacy and Ocular Surface Assessment Between BRIDIN-plus and Combigan in Glaucoma or Ocular Hypertensive

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 8, 2021

Primary Completion Date

December 23, 2022

Study Completion Date

December 23, 2022

Conditions

GlaucomaOcular Hypertensive

Interventions

DRUG

BRIDIN-plus Eye drops

DRUG

Combigan Eye drops

Trial Locations (1)

13497

Seungsoo Rho, Seoul

All Listed Sponsors

collaborator

Hanlim Pharm. Co., Ltd.

INDUSTRY

lead

CHA University

OTHER

NCT06078592 - Comparison of Efficacy and Ocular Surface Assessment Between BRIDIN-plus and Combigan in Glaucoma or Ocular Hypertensive | Biotech Hunter | Biotech Hunter